Cinobufacini retards progression of pancreatic ductal adenocarcinoma through targeting YEATS2/TAK1/NF-κB axis.

MLA

Lan, Tian, et al. “Cinobufacini Retards Progression of Pancreatic Ductal Adenocarcinoma through Targeting YEATS2/TAK1/NF-ΚB Axis.” Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, vol. 109, Jan. 2023, p. 154564. EBSCOhost, https://doi.org/10.1016/j.phymed.2022.154564.

APA

Lan, T., Chen, H.-F., Zheng, F., Huang, H., Wu, Q., Fan, X.-Y., Wang, S.-W., & Zhang, F. (2023). Cinobufacini retards progression of pancreatic ductal adenocarcinoma through targeting YEATS2/TAK1/NF-κB axis. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, 109, 154564. https://doi.org/10.1016/j.phymed.2022.154564

Chicago

Lan, Tian, Hang-Fei Chen, Fang Zheng, Hui Huang, Qi Wu, Xue-Yu Fan, Si-Wei Wang, and Feng Zhang. 2023. “Cinobufacini Retards Progression of Pancreatic Ductal Adenocarcinoma through Targeting YEATS2/TAK1/NF-ΚB Axis.” Phytomedicine : International Journal of Phytotherapy and Phytopharmacology 109 (January): 154564. doi:10.1016/j.phymed.2022.154564.